by admin | Sep 12, 2017 | News
SCOTTSDALE, Ariz., September 12, 2017 Amendola Communications, a nationally recognized, award-winning healthcare and healthcare IT public relations and marketing agency, announced today that Lumeris, a provider of strategic counsel and technology to health systems, hospitals and insurers, has selected Amendola to be a communications partner. Amendola will provide public relations and content creation services to advance the Lumeris brand among key stakeholders in the payer and provider communities.
“Our awarded-winning model to optimize the transition to value-based care is designed for both payers and providers. That’s why we chose an agency that truly has a 360-degree view of the healthcare ecosystem,” said Art Glasgow, president and COO of Lumeris. “The experienced team at Amendola shares our passion for delivering the Triple Aim Plus One and will help us to more widely communicate the important work that we’re doing with customers across the country.”
The Lumeris model of combining consulting services with health IT solutions helps healthcare organizations lower costs, improve outcomes, increase patient satisfaction and engage physicians achieving the goals of the Triple Aim Plus One.
“Lumeris does what few healthcare firms can do works effectively with both payers and providers to help all sides benefit from new risk-sharing contracts,” said Jodi Amendola, CEO of Amendola Communications. “We are excited to introduce this unique perspective to our wide network of media contacts. Our proven track record in promoting healthcare IT companies will help to elevate the Lumeris thought leaders profiles among journalists, prospective clients and the healthcare community at large.”
The agency will work to increase the Lumeris brand identity and spur recognition of Lumeris as a go-to partner for payers and providers seeking strategic counsel and technology to guide their journey from volume to value-based care. Under the partnership agreement, Amendola will be responsible for delivering content demonstrating the thought leadership and expertise of Lumeris subject matter experts including bylined articles, case studies and other materials.
ABOUT LUMERIS
Lumeris brings common sense to healthcare. We provide strategic advising and technology to help providers and payers get back to the way healthcare should be and share in the rewards. We guide health systems and providers through seamless transitions from volume to value, enabling them to deliver improved and more affordable care across populations with better outcomes. And, we work collaboratively with payers to align contracts and engage physicians in programs that drive high-quality, cost-effective care with satisfied consumers and engaged physicians. An industry recognized leader, Lumeris was awarded 2017 Best in KLAS for value-based care managed services for helping clients deliver improved clinical and financial outcomes. This was the second year we received this distinguished award. For the past six years, Essence Healthcare, Lumeris premier client with more than 63,000 members in Missouri and Illinois, has received 4.5 to 5 Stars from the Centers for Medicare and Medicaid Services. We enjoy working with all of our clients, delivering these same results, and aligning our proven multi-payer, multi-population model with their value-based care vision.
by admin | Aug 29, 2017 | News
SCOTTSDALE, Ariz. Aug. 29, 2017 Amendola Communications, an award-winning healthcare marketing and public relations agency, announced today that It’s Never 2 Late (iN2L), the leader in providing person-centered engagement, content and technology solutions for seniors, has selected Amendola Communications as its agency of record. Amendola will provide a range of public relations and content services that promote iN2L as a pioneer and innovator whose mission is to make life worth living for older adults by enabling them to connect, engage and enjoy life leveraging technology.
Previously, iN2L engaged Amendola to elevate its social media presence. The firm successfully executed a program that generated the following results for iN2L in the first six months: 28% new page likes on Facebook; 17% new Twitter followers and 30% new LinkedIn connections.
“I have always been impressed with the Amendola team’s in-depth knowledge of the healthcare IT, long-term care and resident/patient engagement space, as well as their strong commitment to results-oriented client service,” said Tom Bang, chief executive officer of iN2L. “They proactively hit the ground running with several earned article placements in tier one press, multiple media interviews, and strategic guidance from a team of six senior level executives. We’re delighted to be working with them again.”
iN2L works with over 2,000 senior living communities including independent living, assisted living, nursing homes and adult day programs in all 50 states and three countries. iN2L integrates the hardware, software and media with personalized educational and therapeutic content necessary to allow virtually any person with any interest in using a computer, regardless of background, physical or intellectual abilities, to do so pleasurably, engagingly and without frustration.
“A repeat client is a testament to the value we bring to our partnerships,” said Jodi Amendola, CEO of Amendola Communications. “We look forward to advancing iN2L’s mission in the marketplace and to working once again with industry leaders, Tom Bang and Jack York.”
Amendola Communications will provide public relations and marketing communications services, including social media programming, strategic counsel and media relations. The agency will also be responsible for delivering a range of content demonstrating the thought leadership and expertise of iN2L’s subject matter experts, including bylined articles, blog posts, press releases and other communication materials.
About It’s Never 2 Late
It’s Never 2 Late (iN2L) develops digital engagement technology for senior living community residents, with over 2,500 installations in the United States and Canada. The company’s picture-based, touchscreen interface provides easy connectivity to the Internet, regardless of users’ physical and cognitive abilities. iN2L’s media library offers 4,000 social, educational, spiritual and gaming content options. For more information, visit www.in2l.com.
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation by PRSourceCode for four years running, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and healthcare IT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team”, visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
Media Contact:
Marcia Rhodes, Amendola Communications, mrhodes@acmarketingpr.com
by admin | Aug 9, 2017 | News
Agency honored in Content Marketing category for its work on Health Catalyst success story program
SCOTTSDALE, Ariz., August 9, 2017 Amendola Communications, a nationally recognized, award-winning healthcare and healthcare technology public relations and marketing agency, announced today that it has been named a finalist for a PR News Platinum Award in the category of Content Marketing. This distinction is one of several awards the agency has earned in recent years for its ability to develop high-value content for health IT (HIT) organizations that speaks to market needs.
The agency’s entry, “He Said/She Said: Clients Create Credibility for the Health Catalyst Story,” focused on how Amendola Communications worked with client Health Catalyst to build a library of proof points to demonstrate how the client’s solutions resolved issues for other healthcare organizations. Client success stories are highly sought-after in any industry, but especially in healthcare where risk-averse organizations are reluctant to be early adopters of innovation. By developing an extensive library of in-depth success stories, Amendola Communications has been able to help Health Catalyst overcome objections and drive both leads and sales.
“We are thrilled to be named a finalist for a content marketing award beside such great brand names as Coca-Cola, PepsiCo, Southwest Airlines, and J&J,” said Jodi Amendola, CEO of Amendola Communications. “Both our team here and the team at Health Catalyst have put a tremendous amount of effort into making sure we had great success stories to tell and that they were told well. Most clients and agencies are happy if they can pull together three or four of these stories. To develop more than 100 of them since the beginning of 2016 is an amazing accomplishment, and one we are all justifiably proud of. Most important, however, is that the program is accomplishing Health Catalyst’s goal of being a catalyst for massive, sustained improvements in healthcare outcomes.”
The PR News Platinum Awards celebrate the ingenuity and leadership behind the year’s most outstanding communications initiatives. Platinum PR Award winners set industry benchmarks for excellence across all areas of PR. Winners and honorable mentions will be celebrated at an awards luncheon on Thursday, September 14, 2017 at the Grand Hyatt in New York City.
Tweet this: .@AmendolaComm named finalist in @PRNews Platinum Awards | #HIT #ContentMarketing http://bit.ly/2w7D6vM
by admin | Jul 19, 2017 | News
Philip Anast Named Senior Account Director
SCOTTSDALE, Ariz., July 19, 2017 Amendola Communications, a nationally recognized, award-winning healthcare and healthcare technology public relations and marketing agency, announced today that Philip Anast has joined the agency as Senior Account Director. Anast will create and manage client programs, provide strategic counsel and positioning, and pitch media and other digital influencers for the agency’s healthcare/healthcare IT clients.
To download a picture of Anast, click here.
Anast brings 22 years of experience building, managing and executing PR programs for technology providers. He most recently served as vice president of client services for Tech Image, a digital PR agency and subsidiary of SmithBucklin, the world’s largest association management company. As executive team member at Tech Image, Anast was responsible for administering best practices, managing finances and overseeing client relationships in the agency’s hardware-software practice.
During his almost 16 years at the firm, he served supply chain, data integration and digital display clients targeting the HIT vertical and was a regular attendee of RSNA in Chicago since 2008, positioning client diagnostic monitors and other technologies with radiology and other imaging publications. He also served the telecommunications and unified communications sectors, working with providers and equipment manufacturers.
Agency CEO Jodi Amendola said: “Philip brings a deep set of skills and experience launching companies, brands and products across a broad spectrum of technologies, so we look forward to his delivering value to our healthcare/HIT clients. His knowledge positioning technology clients targeting the HIT vertical will bring new perspectives to our already strong Amendola PR and marketing teams.”
“Over the years, I gained familiarity with the work of Jodi and her team, and am grateful for the opportunity now to contribute to Amendola’s growth,” Anast said. “The pace of change affecting today’s businesses is unprecedented, especially in the healthcare sector. New technologies and advances in medicine and approaches to healthcare are disrupting the status quo. I look forward to working with our clients to use the power of storytelling to ensure their unique capabilities and ingenuity reach the right influencers.”
Anast holds M.S. and B.S degrees in Journalism from Northwestern University in Evanston, Ill.
Media Contact: Jodi Amendola | jamendola@ACmarketingPR.com
by admin | Jun 13, 2017 | News
Former bureau chief at MedCity News and senior editor at Medical Economics to direct client accounts at healthcare IT public relations agency
SCOTTSDALE, Ariz., June 13, 2017 Amendola Communications, a nationally recognized, award-winning healthcare and healthcare technology public relations and marketing agency, welcomes Brandon Glenn to the “A-Team.” In his role of account director, Glenn will obtain media coverage and produce top-tier content for the agency’s healthcare and health IT clients. Glenn’s hire signals the agency’s continued commitment to build a roster of talent with deep ties to healthcare IT and business media.
For a headshot of Brandon Glenn, click here.
Amendola Communications CEO Jodi Amendola said, “We’re delighted to have Brandon join us. We expect his industry familiarity and keen reporting skills will quickly result in meaningful media coverage for our clients and heightened awareness of their brands.”
She added, “As a versatile and skilled writer, Brandon will also help us fulfill our clients increasing requests for quality content that differentiates them in a crowded healthcare IT market.”
Glenn brings nearly a decade-and-a-half of journalism and marketing communications experience to his role at Amendola. He gained knowledge and experience in the healthcare industry as Ohio bureau chief at MedCity News, which covers the business of innovation in healthcare, and as a senior editor with Medical Economics, a publication that focuses on issues of importance to primary care physicians. Most recently, he worked in communications with a publicly traded company, handling media relations, content marketing, social media and internal communications.
Glenn began his journalism career as a reporter with Crain’s Cleveland Business and, later, Crain’s Chicago Business. Previously, he worked as an analyst with global consulting firm Accenture. He earned a master’s degree in journalism from Northwestern University’s Medill School of Journalism and a bachelor’s degree in economics from Purdue University.
“I’m excited to join the accomplished team of public relations and marketing experts at Amendola Communications, which I can personally attest is one of the most respected public relations agencies among healthcare IT media professionals,” Glenn said. “I look forward to helping our clients connect with leading healthcare IT journalists and publications to share their stories and advance their businesses.”
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation by PRSourceCode for four years running, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and healthcare IT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team”, visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
Media Contact:
Marcia Rhodes | mrhodes@acmarketingpr.com
by admin | May 30, 2017 | News
Scottsdale, Ariz. May 30, 2017 Amendola Communications, an award-winning healthcare marketing and public relations agency, announced today that Bridge Therapeutics, Inc., has selected Amendola as its agency of record. Bridge Therapeutics, an innovative development-stage specialty pharmaceutical company, will be pursuing FDA and European Medicines Agency (EMA) approval of a patented (U.S. Patent #8410092) novel drug combination for the treatment of chronic pain in opioid-experienced patients.
Bridge selected Amendola after a rigorous agency review process. Amendola will provide a broad range of public relations and thought leadership services that promote Bridge Therapeutics as a pioneer and innovator in improving the lives of patients living with chronic pain through safer, more effective, and less addictive pain management.
Bridge Therapeutics investigational drug compound BT-205 is a unique combination of two synergistic chronic pain drugs the partial-agonist opioid buprenorphine and the NSAID meloxicam delivered in a state-of-the-art sublingual formulation. BT-205 is being developed to replace dangerous, full-agonist opioid-based drugs with a safer and more effective medication.
“We are excited that Amendola Communications will help us to bring our message about safer approaches to those struggling with chronic pain and addiction to the market,” said Alton Kelley, director of business development for Bridge Therapeutics. “Chronic pain affects more 100 million Americans today, which the Institutes of Medicine report is more than diabetes, heart disease and cancer combined. As we go through the FDA and EMA approval and commercialization process, we look forward to partnering with Amendola to help us educate the market about the benefits of replacing dangerous opioid-based drugs with a safer and more effective therapy for those struggling with chronic pain and addiction.”
BT-205 has the potential to be a new treatment option for healthcare providers around the world, and to offer patients an alternative chronic pain therapy. When dosed as a combination drug, buprenorphine and meloxicam have stronger pain relief effects, which allows the use of low dosage strengths of both and reduces the potential for negative side-effects.
Amendola Communications will provide targeted strategic public relations services, including media research, media relations, and the generation of top-tier awards and speaking opportunities. The agency will also be responsible for delivering a range of content demonstrating the thought leadership and expertise of Bridge Therapeutics key opinion leaders (KOLs), including bylined articles, poster presentations, press releases and other materials.
“Bridge Therapeutics offers an exciting and innovative approach to addressing the opioid addiction crisis facing our nation today,” said Jodi Amendola, CEO of Amendola Communications. “Addictive chronic pain drugs today kill more Americans than road crashes, and yet the massive chronic pain market in the United States still lacks a non-addictive pain medication. We look forward to promoting Bridge Therapeutics and its key opinion leaders as the company continues to go through its regulatory approval and commercialization process.”
About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation four times by PRSourceCode, Amendola represents some of the best-known brands and groundbreaking startups in the healthcare and HIT industries. Amendola’s seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry’s “A Team,” visit www.acmarketingpr.com, and follow Amendola on Twitter and LinkedIn.
About Bridge Therapeutics
Bridge Therapeutics, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients. The investigational drug BT-205 is a unique combination of two synergistic chronic pain drugs the partial-agonist opioid buprenorphine and the NSAID meloxicam delivered in a state-of-the-art sublingual formulation. The dosing and delivery method will be a commercial advantage over the current alternatives. Bridge Therapeutics’ goal is to make the BT-205 compound and other investigational new drug candidates available to millions of patients in which addictive and potentially dangerous full-agonist opioids such as oxycodone and morphine are ineffective and/or unsatisfactory. The company is focused on improving the lives of patients living with chronic pain by developing new approaches to pain management that are safer, more effective, and less addictive. For more information, visit www.bridgetherapeutics.com.
Media Contact: Tara Stultz | 440.225.9595 | tstultz@acmarketingpr.com
